SARS-CoV-2 nsp13 Helicase (E. coli expressed)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus and the causative agent of COVID-19, a primarily respiratory illness characterized by fever, cough, and shortness of breath that can lead to life-threatening complications. The SARS-CoV-2 genome contains approximately 30 kilobases and 14 open reading frames (ORFs) that encode four structural proteins: spike, envelope, membrane, and nucleocapsid, as well as 16 non-structural proteins and 9 accessory factors. SARS-CoV-2 nsp13 helicase is a superfamily 1B helicase and component of replicase polyprotein 1a (PP1a), which is encoded by ORF1a in the viral genome. It is composed of two canonical RecA-like ATPase domains, 1A and 2A, and a zinc-binding domain, stalk region, and 1B domain. SARS-CoV-2 nsp13 functions as both an RNA helicase and a nucleoside triphosphate hydrolase (NTPase), unwinding RNA in an NTP-dependent manner. It inhibits IFN-beta reporter gene activation induced by the RIG-I 2CARD domain in 293FT cells, indicating a role for nsp13 helicase in suppression of the host immune response. Cayman's SARS-CoV-2 nsp13 Helicase (E. coli expressed) protein can be used for enzyme assays and Western blot (WB) applications.Synonyms: 2019-nCOV Helicase, COVID-19 Helicase, NSP13, SARS-CoV-2 Helicase, COVID19 Helicase, Severe Acute Respiratory Syndrome Coronavirus 2 nsp13 Helicase. Purity: >70% estimated by SDS-PAGE. Source: Active recombinant N-terminal His-tagged nsp13 helicase expressed in E. coli. Amino Acids: 5,325-5,925. MW: 69.1 kDa. Formulation: (Request formulation change), 50 mM Tris-HCl, pH 7.5, with 5 µM zinc chloride, 1 mM DTT, 1 mM EDTA, and 15% glycerol. UniProt Accession #: P0DTD1.